Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
Cure Parkinson’s Fundraising Heroes: December 2023
To mark the start of a new year, we’re looking back at some fundraising heroes who completed long-term fundraising challenges in support of our research. From bake sales to big events, individual challenges to team efforts, these exceptional fundraisers all raised valuable awareness of the…
Cure Parkinson’s Director of Clinical Development, Dr Richard Wyse, named on His Majesty The King’s New Year’s Honours List
2 January 2024 Cure Parkinson’s Director of Clinical Development, Dr Richard Wyse, has been selected for His Majesty The King’s New Year’s Honours List, for services to medicine in Parkinson’s disease. Dr Wyse has built an innovative, game-changing programme of research for Parkinson’s; he has…
Dr Richard Wyse named in His Majesty The King’s New Year’s Honours List
Dr. Richard Wyse, Cure Parkinson’s Director of Clinical Development, has been recognised with a prestigious inclusion in His Majesty The King’s New Year’s Honours List, for services to medicine in Parkinson’s disease.
Royal Parks Half Marathon 2025
Take in London’s famous landmarks and leafy parks when you run the Royal Parks Half Marathon, all to raise vital funds for Cure Parkinson’s. The incredible 13.1 mile route takes you through four of the eight Royal Parks – Hyde Park, Green Park, St James’s...
Alpha-synuclein or Tau in Parkinson’s?
The build-up of a protein called alpha-synuclein has been considered one of the hallmarks of Parkinson’s. Recently, however, a group of scientists have called into question the ‘bad guy’ role of alpha-synuclein.